Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Seres Therapeutics, Inc.
< Previous
1
2
3
Next >
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 08, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
April 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 05, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
February 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
February 27, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
February 26, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
January 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
December 07, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
November 28, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million
November 02, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST
October 30, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Highlight VOWST™ Data at IDWeek
October 12, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 06, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 08, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 07, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 08, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Host Second Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on August 8, 2023
August 01, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 14, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Named to TIME100 Most Influential Companies List
June 21, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023
June 17, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Present at Goldman Sachs Global Healthcare Conference
June 09, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 09, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.